OncoSec Medical Inc (ONCSQ)

[James salmon]

I agree and no doubt that ONCS had buyers lined up for the offering.

Trial results so far have been good in a patient population with very poor prognosis.

I was surprised to see offering after RS but with this money I don’t see any need to raise anymore capital for sometime and certainly after we know if we are looking at accelerated approval and by then I expect a deal with Merck.

I bought more yesterday as well.